Is Ozempic (semaglutide) a contraindication to receiving a rabies booster vaccine in a patient with type 2 diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

No Contraindication Between Ozempic and Rabies Booster

Ozempic (semaglutide) is not a contraindication to receiving a rabies booster vaccine in patients with type 2 diabetes. There are no documented interactions between GLP-1 receptor agonists and any vaccines, including rabies vaccination 1.

Evidence Supporting Safe Co-Administration

Vaccine Safety in Diabetes Patients

  • Vaccination in diabetic patients is safe and free of risk provided general contraindications (such as allergy to vaccine components or severe acute febrile illness) are respected 2
  • A retrospective study of 402 diabetic patients receiving various vaccines showed not a single unexpected side effect following vaccination procedures 2
  • Diabetic patients can benefit from vaccination more remarkably than the general population since it may have life-saving potential 2

Rabies Vaccination Guidelines

  • The ACIP rabies prevention guidelines establish that postexposure prophylaxis should include both rabies immune globulin (RIG) and vaccine, with no mention of diabetes medications as contraindications 1
  • The recommended rabies vaccine regimen consists of five 1-mL doses administered intramuscularly on days 0,3,7,14, and 28, with no restrictions based on concurrent medications 1

Semaglutide-Specific Considerations

  • The established contraindications for semaglutide include personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, pregnancy/breastfeeding, and severe hypersensitivity reactions to the drug 1, 3
  • Vaccines are not listed among medications requiring caution or dose adjustment when used with semaglutide 1, 4

Practical Management Approach

Proceed with rabies booster vaccination without interrupting Ozempic therapy. The patient should:

  • Continue their regular Ozempic dosing schedule without modification 1, 4
  • Receive the rabies booster according to standard ACIP guidelines 1
  • Monitor for typical vaccine side effects (injection site reactions, mild fever) which are unrelated to diabetes medication 1

Important Caveats

  • If the patient has unstable glycemia or significantly impaired immune function due to poorly controlled diabetes, this relates to vaccine efficacy concerns rather than semaglutide contraindications 2
  • Live attenuated vaccines (which rabies vaccine is NOT) require more careful consideration in immunocompromised diabetic patients, but this is a diabetes-related concern, not a semaglutide-specific issue 2
  • The only medication interaction concern with semaglutide involves insulin, sulfonylureas, or glinides due to hypoglycemia risk—not vaccines 1, 3

There is no medical reason to delay, modify, or withhold rabies vaccination in a patient taking Ozempic.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Vaccination of patients with diabetes mellitus--a retrospective study.

Central European journal of public health, 2011

Guideline

Pharmacological Management of Obesity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Oral Semaglutide for Type 2 Diabetes Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.